ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 762545 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 762545; 2) Community: the network communities that were significantly associated with the response to NSC 762545; 3) Molecule: the relationships between components within communities and NSC 762545; 4) MDR: the compounds that were significantly associated with the NSC 762545.

NSC Compound Enrichment Correlation
NSC 702129 Null 0.0183522248172066 0.56017866
NSC 736049 N-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N'-(2-met hylimidazo[1,2-a]pyridin-3-yl)urea 0.0183522248172066 0.63809269
NSC 93354 Null 0.0183522248172068 -0.095496637
NSC 107043 Null 0.0210461623330205 -0.19969236
NSC 176323 Camptothecin Derivative 0.0210461623330205 -0.08404979
NSC 208885 Null 0.0210461623330205 -0.046274391
NSC 319947 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- 0.0210461623330205 -0.30182616
NSC 372939 Null 0.0210461623330205 -0.30201069
NSC 58573 Pyrimidine, 2,4,5-trichloro-6-ethyl- 0.0210461623330205 -0.3556528
NSC 642009 Butanedioic acid, 2-[[2-[(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)amino]1,2-dioxo]ethyl]-3-oxo-, dimethyl ester 0.0210461623330205 -0.19116026
Total:56  Current:25    [First] [Prev] [Next] [Last]